Venous thromboembolic disease: Clinical Practice Guidelines in Oncology™ Journal Article
| Authors: | Wagman, L. D.; Baird, M. F.; Bennett, C. L.; Bockenstedt, P. L.; Cataland, S. R.; Fanikos, J.; Fogarty, P. F.; Goldhaber, S. Z.; Grover, T. S.; Haire, W.; Hassoun, H.; Jahanzeb, M.; Leung, L. L.; Linenberger, M. L.; Millenson, M. M.; Ortel, T. L.; Salem, R.; Smith, J. L.; Streiff, M. B. |
| Article Title: | Venous thromboembolic disease: Clinical Practice Guidelines in Oncology™ |
| Abstract: | Recognizing the increased risk of VTE in cancer patients is the first step in preventing the occurrence of VTE and promptly identifying the disease in cancer patients. The NCCN panel recommends VTE thromboprophylaxis for all hospitalized patients with cancer who do not have contraindications to such therapy, and the panel also emphasizes that an increased level of clinical suspicion of VTE should be maintained for cancer patients. Careful evaluation and follow-up of cancer patients in whom VTE is suspected and prompt treatment and follow-up for patients diagnosed with VTE is recommended after the cancer status of the patient and the risks and benefits of treatment are considered. © Journal of the National Comprehensive Cancer Network. |
| Keywords: | cancer chemotherapy; lenalidomide; thalidomide; clinical feature; clinical trial; review; doxorubicin; drug potentiation; pathophysiology; cancer patient; antineoplastic agent; diagnostic procedure; unindexed drug; protective clothing; thrombocytopenia; prevalence; nccn clinical practice guidelines; dexamethasone; anticoagulant therapy; deep vein thrombosis; practice guideline; risk assessment; lung embolism; pulmonary embolism; drug antagonism; drug mechanism; conservative treatment; acetylsalicylic acid; thromboembolism; nonsteroid antiinflammatory agent; ciprofloxacin; warfarin; heparin; medical oncology; tamoxifen; diethylstilbestrol; anticoagulation; drug half life; treatment contraindication; metronidazole; oral contraceptive agent; treatment withdrawal; enoxaparin; fondaparinux; lepirudin; low molecular weight heparin; venous thromboembolism; anticoagulant agent; argatroban; dalteparin; tinzaparin; vena cava filters; raloxifene; drug elimination; antiinflammatory agent; catheter thrombosis; recombinant blood clotting factor 7a; hirulog; venous thrombosis; deep venous thrombosis; blood clotting factor 10a inhibitor; thrombin inhibitor; thrombophlebitis; dicloxacillin |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 4 |
| Issue: | 9 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2006-10-01 |
| Start Page: | 838 |
| End Page: | 869 |
| Language: | English |
| PUBMED: | 17020664 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 30" - "Export Date: 4 June 2012" - "Source: Scopus" |
